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Birth defects or congenital anomalies are one of the major causes of disability in developed
and developing countries. Data on birth defects from population-based studies originating
from developing countries are lacking. Increasingly, there is a shift to genetic testing and
genomics study of birth defects. However, the translation from bench findings to bedside
medicine has been muted. There is a need to address this imbalance where congenital
anomalies remained the top etiology for neonatal mortality in developing countries. To
build capacity in low resource countries, there is a need for accurate collection and ascer-
tainment of birth defects in developing countries.The systematic collection and analysis of
data on major birth defects using birth defects registries (BDRs) are an integral part of all
clinical genetic services. Healthcare planners in developing countries must be aware of the
advantages and limitations of BDRs. Despite the advent of the genomics era, BDRs are
essential to the planning and developing care and prevention services at local and national
levels, particularly in low resource or developing countries.
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INTRODUCTION
Birth defects or congenital anomalies are one of the major causes
of disability in developed and developing countries (1, 2). Data
on birth defects from population-based studies originating from
developing countries in the Asia-Pacific region are lacking (3).
The March of Dimes estimated 7.4 million infants are born each
year with a serious birth defect. Of these births, 94% occur in
middle and low income countries (4). Over 3.3 million children
under age five die annually from birth defects. The etiology for
birth defects is heterogenous and there are a number of preven-
tative strategies that can be adopted to reduce them (5, 6). With
the development of newer technologies in genomics medicine,
it is possible to characterize the molecular bases of many rare
disorders and birth defects (7, 8). Increasingly, there are data-
bases established for a single specified condition to study the
phenotype–genotype correlations or genomic variations within
the disorder (9). Hence, there is a need to re-visit the roles of birth
defects registers. This is especially important in parts of the world
where congenital anomalies remained a major cause of neonatal
mortality and morbidity (10).
The systematic collection and analysis of data on major birth
defects using a birth defect register (BDR) has traditionally being
an integral part of a clinical genetic service (11, 12). This requires
the strengthening of medical genetic services in low- and middle-
income countries (13) Reliable data birth defects rely on the
on-going surveillance on the types, birth prevalence, severity, and
outcome of children with birth defects. Sources of information
that contribute to the BDR include health professionals, special
treatment centers, and private hospitals and healthcare practices,
autopsy services, and laboratory diagnostic services. The notifi-
cation of birth defects may be done under a voluntary basis or
under the authority of legislation. The methods of ascertainment
used are important as active system of case notification will yield
a higher number of cases than passive notification. There is a
need to obtain ethical approval to review patient case files from all
hospitals and healthcare facilities to ensure that patient privacy is
protected and confidentiality of information assured.
FUNCTIONS AND LIMITATIONS OF A BIRTH DEFECTS
REGISTER
The functions of a BDR are manifold. It helps to establish local
prevalence rates for birth defects in the local population as well
as to facilitate and determine accurate baseline incidence and
detection of trends of birth defects. This will be essential to the
planning of health care facilities, allocation of appropriate health
resources required for the design, and implementation of various
preventative programs, training of medical, and paramedical staff
to provide the skills to recognize major birth defects within the
framework of public health (11) and facilitating access to genetic
counseling services (14). Genetic counseling is not easily available
in most health services and a BDR may serve as a nucleus to train
providers of genetic counseling, population screening, and pub-
lic education (14, 15). With such amenities, pre-natal diagnosis
for specific genetic disease can be achieved for at-risk families A
BDR also function to monitor the occurrence of defects over time
and by geographical area to allow earlier detection of the emer-
gence of any new teratogen and further investigations of suspected
teratogens (16, 17). It can be used to perform epidemiological
studies to identify the causation of birth defect, for clinical research
(18), and to increase community knowledge about birth defects
through education. Empowerment of the members of the public
with knowledge regarding birth defects is essential to ensure suc-
cess of any preventive programs. For example, valproate should
not be first-line anti-epileptic drugs (AED) for women who are
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considering pregnancy. In this situation, this drug is best avoided
if other effective but safer AEDs can be found for each individual
woman’s seizure disorder (19). When valproate cannot be avoided
in pregnancy, the lowest possible effective dose should be pre-
scribed in two to three divided doses, preferably as monotherapy.
Women exposed to valproate in pregnancy should be given peri-
conceptional folic acid and followed up in a high risk pregnancy
clinic (20).
It is to be expected that there are a number of difficulties and
limitations arising from the planning and maintenance of a BDR.
Many medical practitioners are bewildered by the various terms
used in a BDR. For example, the terms “congenital abnormalities,”
“congenital disorders,” “congenital anomalies or malformations,”
and “birth defects” have been used interchangeably in some cen-
ters although specific definitions are available for the above. The
March of Dimes used “birth defects” and these include abnor-
malities in structure or function, including metabolism, which
are present from birth. The World Health Organization (WHO)
Human Genetics Programme (HGN) prefers “congenital disor-
der,” which is defined as any potential pathological condition
arising before birth, including all disorders caused by environmen-
tal, genetic, or unknown factors, whether they are evident at birth
or become manifest later in life. The WHO Burden of Disease Unit
uses “congenital anomalies” defined as macroscopic morpholog-
ical anomalies present from birth. This excludes functional birth
defects, disability, common single gene disorders such as cystic
fibrosis and glucose-6-phosphate dehydrogenase deficiency and
inborn errors of metabolism. In a report of a joint WHO-March of
Dimes meeting in 2006, it was decided that the term “birth defect”
is synonymous with the term “congenital disorder” as defined and
used by the HGN (13).
Another difficult issue has been ascertainment of infants with
multiple birth defects. This may require the assessment of a clin-
ical geneticist to make a syndromic diagnosis or to perform the
appropriate investigations. Increasingly, pre-natal diagnosis and
termination of pregnancies are performed in many communi-
ties. This may reduce the births of newborns with birth defects
but the true prevalence remains the same. Hence, many BDR
include termination of pregnancies in the data collection. The
timing of the case ascertainment may also cause variations in
the data collection. Increasingly, there are many databases estab-
lished to register patients with some specific disorders and the
main objective is to study the phenotype–genotype correlations
or genomic variations within the disorder (9). These databases
may draw away further financial support and genetic expertise
away from the BDR.
There have been few studies in developing countries on the cost-
effectiveness of BDR and long-term benefits are uncertain (11).
Many medical or health care planners are reluctant or unable to
commit public funds for medical registers due to the lack of defin-
itive evidence of cost-effectiveness. There may be underutilization
of the data in the BDR due to lack of expertise or research fund-
ing, for example, to maintain a teratogen warning system. There
is a need to increase public and professional awareness on birth
defects and to facilitate research collaboration, locally, and region-
ally. Collaboration with the public health sector or “public health
genomics” may result in specific targeted preventive programs for
birth defects. With increased public or consumer sensitization to
birth defects, the issue of stigmatization and marginalization of
individuals with birth defects may be further reduced (14). Hence,
it is vital for healthcare planners to be aware of these challenges
and opportunities provided by a BDR.
SETTING UP A BIRTH DEFECTS REGISTER
The setting up of a Birth Defects Register requires careful and
detailed planning with extensive consultation with various experts
and open collaboration with many professional groups and health-
care services. The staff of the BDR may consists of clinical geneti-
cist, pediatrician, obstetrician, representative from the maternal
and child health service, epidemiologist and biostatistician, data
manager, nursing staff, and clerical assistants. It also requires
assured sources of funding as the health returns from a BDR may
not be evident for many years. Frequently, experts from the public
health and community genetics work closely together to design a
program that will be the most suitable for the local situation. A
BDR may be population-based or hospital-based.
A BDR may need to decide whether to include all major birth
defects or just sentinel birth defects. Ideally, all major birth defects
should be included in a BDR. Some BDR have advocated sentinel
defects only and these are usually birth defects that are evident at
birth on inspection. The disadvantage of this is that major birth
defects arising in certain population or following a teratogenic
effect may be missed if reporting is based on sentinel findings
that are not involved. Due to logistical difficulties, some BDR may
opt to report birth defects in certain regions or localities only,
rather than cover the entire population. Another important aspect
is that the BDR must operate within the framework of the cur-
rent health system and services. A BDR is usually governmental in
origin although non-governmental organizations may be an active
participant in the program. An important factor for a BDR to con-
sider is to provide timely and up-to-date feedback to stakeholders
of the program. This may include the members of the medical
profession, health care planners, and hospitals and services that
contributed to the BDR.
BIRTH DEFECTS REGISTRIES IN THE ASIA-PACIFIC REGION
In South-East Asia, only Singapore has a National BDR, which
was established in 1992. It is population-based and funded by the
government. It collects all major and minor birth defects but not
inborn errors of metabolism. The common birth defects are con-
genital heart defects, cleft lip and palate, gastrointestinal defects,
neural tube defects, and limb defects (21). More than 20% of med-
ically certified infant deaths in Malaysia were classified as due to
birth defects in 1990. As the data collected were hospital-based, a
pilot study to set up a population-based BDR was initiated in 2000
(10). The results showed the prevalence of birth defects were 1 in 70
and several risk factors were identified. It recommended pre-natal
and antenatal screening for insulin dependent diabetes, genetic
counseling, and investigating causes for previous abortions and
public education on avoidance of teratogens. It also emphasized
the role of periconceptional folic acid supplementation or food
fortification. Of concern was that only 15% of the birth defects
were detected during the antenatal period (22). The main birth
defects were chromosomal disorders, congenital heart disease,
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cleft lip and palate, club feet, and central nervous system defects.
The population-based study was the first such study in Malaysia.
Several hospital-based birth defects registers were also started (23).
As a long-term follow-up, a section on birth defects were included
in the Malaysian National Neonatal Registry (MNNR), beginning
from 2005. This has yielded important data on many birth defects,
for example, the MNNR provided detailed information on the
incidence of neural tube defects in various localities in Malaysia,
identified needs and proposed various targeted recommendations
(24). In 2006, the Ministry of Health of Malaysia reported that
the number one cause of under-five deaths were congenital anom-
alies (25). In the Philippines, several pilot projects on congenital
anomalies were started (26). In 2008, a Birth Defects Surveillance
Project was announced and was coordinated from the Institute of
Human Genetics, National Institutes of Health with funding pro-
vided by the Department of Health, University of Philippines and
March of Dimes Foundation. It was both hospital-based and com-
munity based and only physical defects were included. The major
birth defects found in the pilot studies were ankyloglossia, multiple
birth defects (not elsewhere classified), cleft lip and palate, talipes
equinovarus, and anencephaly. The Sixth International Confer-
ence on Birth Defects and Disabilities in the Developing World
was recently held in Cebu City, Philippines on the 10–13th of
November 2013.
CONCLUSION
The systematic collection and analysis of data on major birth
defects using BDRs are an integral part of all clinical genetic ser-
vices. Healthcare planners in developing countries must be aware
of the advantages and limitations of BDRs. Despite the advent of
the genomics era, BDRs are essential to the planning and devel-
oping care and prevention services at local and national levels,
particularly in low resource or developing countries.
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